News

Physical/functional limitations top risk factor for late-life depression


 

FROM PREVENTIVE MEDICINE

References

New findings show there are several major risk factors that influence late-life depression (LLD), with physical/functional limitations the most prevalent, according to Shun-Chiao Chang, ScD, of Brigham and Women’s Hospital, Boston, and her associates.

They examined 21,728 women aged older than 65 years who had no prior depression. During a 10-year follow-up, 3,945 incident LLD cases were identified. In those cases, social factors and lifestyle/behavioral factors did affect LLD, but the categories with the largest effect magnitudes for higher LLD risk were severe/very severe bodily pain (hazard ratio, 2.22; 95% confidence interval, 1.88-2.62), difficulty sleeping most/all the time (HR, 2.04; 95% CI, 1.77-2.36), and daily sleep of 10 hours or more (HR, 1.96; 95% CI, 1.56-2.46). The most prevalent risk factor, physical/functional limitations, was associated with a 42% increase in risk

©giocalde/Thinkstock

Sleep difficulty some to all of the time, no/very little exercise, and moderate to very severe bodily pain also were factors, with population attributable fraction (PAF) values of 10% or higher. The factor with the largest PAF was physical/functional limitation (26.4%).

Overall, the behavioral factors appeared to contribute relatively equally to LLD among women with and without physical/functional limitations; however, health factors had much bigger contributions to risk among women with limitations.

“Together, model predictors accounted for almost 60% of all new LLD cases in this population, and physical/functional limitation is the largest single contributor to total risk,” the researchers concluded. “A substantial proportion of LLD cases may be preventable by increasing exercise and intervening or preventing sleep difficulties and pain.”

Find the full study in Preventive Medicine (doi: 10.1016/j.ypmed.2016.08.014).

llaubach@frontlinemedcom.com

Recommended Reading

Medicare annual wellness visit remains underused
MDedge Psychiatry
VIDEO: Proposed Alzheimer’s funding boost could mean wider research scope
MDedge Psychiatry
VIDEO: Alzheimer’s anti-tau drug fails, but shows hint of effect when taken alone
MDedge Psychiatry
Alzheimer’s anti-tau drug fails phase III, but posts some benefit in monotherapy subanalysis
MDedge Psychiatry
Driving skills already affected with mild cognitive impairment
MDedge Psychiatry
VIDEO: A case study in diagnosing depression or demoralization after retirement
MDedge Psychiatry
Early Alzheimer’s treatment decreases both costs and mortality
MDedge Psychiatry
Retinal nerve fiber layer thinning predicts cognitive decline
MDedge Psychiatry
Major depressive disorder increases acute MI risk in HIV
MDedge Psychiatry
VIDEO: Smell test reflects brain pathologies, risk of Alzheimer’s progression
MDedge Psychiatry